Slow Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-149,137
Closed -$15.1M 111
2025
Q4
$15.1M Buy
149,137
+75,662
+103% +$6.08M 1.81% 13
2025
Q3
$4.02M Sell
73,475
-6,780
-8% -$339K 0.47% 63
2025
Q2
$4.26M Buy
80,255
+1,308
+2% +$66.5K 0.52% 56
2025
Q1
$3.42M Sell
78,947
-3,054
-4% -$155K 0.46% 67
2024
Q4
$4.61M Buy
82,001
+5,346
+7% +$333K 0.65% 39
2024
Q3
$5.22M Buy
76,655
+3,843
+5% +$217K 0.8% 32
2024
Q2
$3.08M Buy
72,812
+3,010
+4% +$166K 0.5% 64
2024
Q1
$4.82M Buy
69,802
+4,463
+7% +$282K 0.77% 33
2023
Q4
$4.83M Sell
65,339
-1,114
-2% -$73K 0.84% 25
2023
Q3
$4.53M Sell
66,453
-1,579
-2% -$134K 0.83% 25
2023
Q2
$6.39M Sell
68,032
-2,208
-3% -$172K 1.11% 22
2023
Q1
$4.76M Sell
70,240
-59
-0.1% -$3.79K 0.89% 27
2022
Q4
$3.48M Buy
70,299
+1,963
+3% +$80.2K 0.77% 35
2022
Q3
$2.22M Buy
68,336
+13,710
+25% +$565K 0.48% 56
2022
Q2
$2.15M Buy
+54,626
New +$2.92M 0.52% 63

Other funds holding EXAS

Slow Capital's EXAS Position: Q1 2026 in Review

Slow Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 149,137 shares — an estimated $15.1M sold.

Slow Capital first reported a position in EXAS in Q2 2022 and held it in 15 quarters. The position peaked at $15.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Slow Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Slow Capital sold 149,137 Exact Sciences shares in Q1 2026, an estimated $15.1M.
  • Slow Capital first reported a position in Exact Sciences in Q2 2022 and held it in 15 quarters.
  • Slow Capital's Exact Sciences position peaked at $15.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Slow Capital's 13F filing for Q1 2026, filed 24 Apr 2026.